Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Endocrine disruptors may cause early hair loss.

Testosterone may slow down wound healing and increase inflammation.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Birds can regenerate inner ear cells using specific gene pathways, unlike mammals.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Oral contraceptives may cause hair loss in women.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.